• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估在第二次显微睾丸精子提取前用睾酮进行下调的新辅助促性腺激素给药:一项前瞻性病例对照研究。

Evaluation of neoadjuvant gonadotropin administration with downregulation by testosterone prior to second time microsurgical testicular sperm extraction: A prospective case-control study.

机构信息

Andrology & STDs Department, Kasr Al-Ainy Faculty of Medicine, Cairo University, Cairo, Egypt.

Adam International Hospital, Giza, Egypt.

出版信息

Urologia. 2020 Nov;87(4):185-190. doi: 10.1177/0391560320913401. Epub 2020 Apr 23.

DOI:10.1177/0391560320913401
PMID:32323641
Abstract

PURPOSE

The aim of this prospective study was to determine whether there is a beneficial role of combining gonadotropin administration with testosterone downregulation in non-obstructive azoospermia patients prior to a second time microsurgical testicular sperm extraction after a negative one.

METHODS

A total of 40 non-obstructive azoospermia men were recruited from a specialized IVF center from 2014 to 2016. Participants were divided equally into two groups: Group A was subjected to testosterone downregulation alone for 1 month and then combined with gonadotropin administration for 3 months prior to second time testicular sperm extraction; Group B (controls) underwent second time microsurgical testicular sperm extraction without prior hormonal therapy.

RESULTS

Mean baseline follicle-stimulating hormone levels of the controls and the cases were 26.9 ± 11.8 and 25.4 ± 8.7, respectively. One month after testosterone downregulation, follicle-stimulating hormone level of the cases was normalized and became 2.4 ± 1.2. There was no statistically significant difference between baseline follicle-stimulating hormone levels of the controls and cases (p = 0.946). Remarkably, two cases were positive after downregulation (10%) and no controls were positive at second testicular sperm extraction (0%). There was no statistically significant difference between sperm retrieval after the second microsurgical testicular sperm extraction in the controls and the cases (p = 0.072).

CONCLUSION

Patients who underwent first time testicular sperm extraction with unfavorable outcome due to different techniques may benefit from testosterone downregulation combined with neoadjuvant gonadotropin administration as it had shown positive sperms retrieval in 2 out of the 20 cases, especially those with hypergonadotropic azoospermia.

摘要

目的

本前瞻性研究旨在确定在首次失败的睾丸精子提取术之后,对非梗阻性无精子症患者进行第二次显微睾丸精子提取术之前,联合使用促性腺激素给药和睾酮下调是否具有有益作用。

方法

2014 年至 2016 年,从一家专门的体外受精中心招募了 40 名非梗阻性无精子症男性。参与者被平均分为两组:A 组仅接受睾酮下调治疗 1 个月,然后在第二次睾丸精子提取术之前联合使用促性腺激素给药治疗 3 个月;B 组(对照组)未进行激素治疗,直接进行第二次显微睾丸精子提取术。

结果

对照组和病例组的基础卵泡刺激素水平分别为 26.9±11.8 和 25.4±8.7。睾酮下调 1 个月后,病例组的卵泡刺激素水平正常化,达到 2.4±1.2。对照组和病例组的基础卵泡刺激素水平无统计学差异(p=0.946)。值得注意的是,下调后有 2 例(10%)呈阳性,而对照组在第二次睾丸精子提取术时均为阴性(0%)。对照组和病例组在第二次显微睾丸精子提取术后的精子获取率无统计学差异(p=0.072)。

结论

由于不同的技术,首次睾丸精子提取术结果不佳的患者可能受益于睾酮下调联合新辅助促性腺激素给药,因为它显示出在 20 例中有 2 例(10%)获得了阳性精子,特别是那些高促性腺激素无精子症患者。

相似文献

1
Evaluation of neoadjuvant gonadotropin administration with downregulation by testosterone prior to second time microsurgical testicular sperm extraction: A prospective case-control study.评估在第二次显微睾丸精子提取前用睾酮进行下调的新辅助促性腺激素给药:一项前瞻性病例对照研究。
Urologia. 2020 Nov;87(4):185-190. doi: 10.1177/0391560320913401. Epub 2020 Apr 23.
2
Optimization of spermatogenesis-regulating hormones in patients with non-obstructive azoospermia and its impact on sperm retrieval: a multicentre study.优化非梗阻性无精子症患者的生精调节激素及其对精子获取的影响:一项多中心研究。
BJU Int. 2013 Mar;111(3 Pt B):E110-4. doi: 10.1111/j.1464-410X.2012.11485.x. Epub 2012 Sep 7.
3
The effect of human chorionic gonadotropin-based hormonal therapy on intratesticular testosterone levels and spermatogonial DNA synthesis in men with non-obstructive azoospermia.人绒毛膜促性腺激素为基础的激素治疗对非梗阻性无精子症患者睾丸内睾酮水平和精原细胞 DNA 合成的影响。
Andrology. 2013 Nov;1(6):929-35. doi: 10.1111/j.2047-2927.2013.00141.x. Epub 2013 Oct 2.
4
Salvage hormonal therapy after failed microdissection testicular sperm extraction: A multi-institutional prospective study.显微外科睾丸精子提取失败后的挽救性激素治疗:一项多机构前瞻性研究。
Int J Urol. 2016 Jun;23(6):496-500. doi: 10.1111/iju.13076. Epub 2016 Mar 14.
5
Human chorionic gonadotrophin treatment prior to microdissection testicular sperm extraction in non-obstructive azoospermia.人绒毛膜促性腺激素预处理在非梗阻性无精子症的睾丸显微取精术中的应用。
Hum Reprod. 2012 Feb;27(2):331-9. doi: 10.1093/humrep/der404. Epub 2011 Nov 28.
6
Role of optimizing testosterone before microdissection testicular sperm extraction in men with nonobstructive azoospermia.优化非梗阻性无精子症患者睾丸精子提取前的睾酮水平的作用。
J Urol. 2012 Aug;188(2):532-6. doi: 10.1016/j.juro.2012.04.002. Epub 2012 Jun 15.
7
Effects of human chorionic gonadotropin on testicular interstitial tissues in men with non-obstructive azoospermia.人绒毛膜促性腺激素对非梗阻性无精子症男性睾丸间质组织的影响。
Andrology. 2017 Mar;5(2):232-239. doi: 10.1111/andr.12292. Epub 2016 Nov 16.
8
Testosterone levels among non-obstructive azoospermic patients 2 years after failed bilateral microdissection testicular sperm extraction: a nested case-cohort study.非梗阻性无精子症患者双侧显微睾丸精子抽吸术失败 2 年后的睾酮水平:一项巢式病例对照研究。
J Assist Reprod Genet. 2022 Jun;39(6):1297-1303. doi: 10.1007/s10815-022-02497-x. Epub 2022 Apr 25.
9
Relevance of testicular histopathology on prediction of sperm retrieval rates in case of non-obstructive and obstructive azoospermia.睾丸组织病理学对非梗阻性和梗阻性无精子症患者精子获取率预测的相关性。
Urologia. 2018 May;85(2):60-67. doi: 10.1177/0391560318758940. Epub 2018 Mar 23.
10
Serum hormones in patients with nonobstructive azoospermia after microdissection testicular sperm extraction.显微取精术后非梗阻性无精子症患者的血清激素水平
J Urol. 2009 Oct;182(4):1495-9. doi: 10.1016/j.juro.2009.06.029. Epub 2009 Aug 15.

引用本文的文献

1
Evaluation of the predictors of successful sperm retrieval of micro-TESE in cases with mosaic Klinefelter versus cases with non-mosaic Klinefelter: a prospective case series study.克氏综合征嵌合型与非嵌合型病例中显微睾丸精子提取术成功获取精子的预测因素评估:一项前瞻性病例系列研究。
Basic Clin Androl. 2025 May 19;35(1):18. doi: 10.1186/s12610-025-00265-2.
2
The role of luteinizing hormone activity in spermatogenesis: from physiology to clinical practice.黄体生成素活性在精子发生中的作用:从生理学到临床实践
Reprod Biol Endocrinol. 2025 Jan 13;23(Suppl 1):6. doi: 10.1186/s12958-024-01333-4.
3
Medical treatment prior to micro-TESE.
显微睾丸取精术前的医学治疗。
Asian J Androl. 2025 May 1;27(3):342-354. doi: 10.4103/aja202492. Epub 2024 Dec 24.
4
Second chance in fertility: a comprehensive narrative review of redo micro-TESE outcomes after initial failure.生育的第二次机会:对初次失败后再次进行显微睾丸取精术结果的全面叙述性综述
Asian J Androl. 2025 May 1;27(3):409-415. doi: 10.4103/aja202446. Epub 2024 Jul 19.
5
2023 Canadian Urological Association guideline: Evaluation and management of azoospermia.2023年加拿大泌尿外科学会指南:无精子症的评估与管理
Can Urol Assoc J. 2023 Aug;17(8):228-240. doi: 10.5489/cuaj.8445.
6
Does hormonal therapy improve sperm retrieval rates in men with non-obstructive azoospermia: a systematic review and meta-analysis.激素治疗是否能提高非梗阻性无精子症患者的精子获取率:系统评价和荟萃分析。
Hum Reprod Update. 2022 Aug 25;28(5):609-628. doi: 10.1093/humupd/dmac016.
7
Hormonal Treatment of Men with Nonobstructive Azoospermia: What Does the Evidence Suggest?非梗阻性无精子症男性的激素治疗:证据表明了什么?
J Clin Med. 2021 Jan 20;10(3):387. doi: 10.3390/jcm10030387.